摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-{2-(tert-butyldiphenylsilyloxy)ethyl}-N-{2-[6-O-benzyl-2-deoxy-3-O-((R)-3-tetradecanoyloxytetradecanoyl)-2-(2,2,2-trichloroethoxycarbonylamino)-β-D-glucopyranosyloxy]ethyl}-2,2,2-trichloroethoxymethanamide | 1428739-44-9

中文名称
——
中文别名
——
英文名称
N-{2-(tert-butyldiphenylsilyloxy)ethyl}-N-{2-[6-O-benzyl-2-deoxy-3-O-((R)-3-tetradecanoyloxytetradecanoyl)-2-(2,2,2-trichloroethoxycarbonylamino)-β-D-glucopyranosyloxy]ethyl}-2,2,2-trichloroethoxymethanamide
英文别名
——
N-{2-(tert-butyldiphenylsilyloxy)ethyl}-N-{2-[6-O-benzyl-2-deoxy-3-O-((R)-3-tetradecanoyloxytetradecanoyl)-2-(2,2,2-trichloroethoxycarbonylamino)-β-D-glucopyranosyloxy]ethyl}-2,2,2-trichloroethoxymethanamide化学式
CAS
1428739-44-9
化学式
C67H100Cl6N2O13Si
mdl
——
分子量
1382.34
InChiKey
WZZDIXUQDBTPDM-QQEKSEBDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    15.99
  • 重原子数:
    89.0
  • 可旋转键数:
    43.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    177.62
  • 氢给体数:
    2.0
  • 氢受体数:
    13.0

反应信息

  • 作为反应物:
    描述:
    N-{2-(tert-butyldiphenylsilyloxy)ethyl}-N-{2-[6-O-benzyl-2-deoxy-3-O-((R)-3-tetradecanoyloxytetradecanoyl)-2-(2,2,2-trichloroethoxycarbonylamino)-β-D-glucopyranosyloxy]ethyl}-2,2,2-trichloroethoxymethanamide二苯基N,N'-二异丙基亚磷酰胺5-苯基四氮唑间氯过氧苯甲酸 作用下, 以 二氯甲烷 为溶剂, 反应 2.0h, 以85%的产率得到N-{2-(tert-butyldiphenylsilyloxy)ethyl}-N-{2-[6-O-benzyl-2-deoxy-4-O-(di-O-benzylphosphono)-3-O-((R)-3-tetradecanoyloxytetradecanoyl)-2-(2,2,2-trichloroethoxycarbonylamino)-β-D-glucopyranosyloxy]ethyl}-2,2,2-trichloroethoxymethanamide
    参考文献:
    名称:
    Improving the immunostimulatory potency of diethanolamine-containing lipid A mimics
    摘要:
    Lipid A is the active principal of gram negative bacterial lipopolysaccharide (LPS) in the activation of Toll-like receptor 4 (TLR4). Given the important role TLR4 plays in innate immunity and the development of adaptive immune responses, ligands that can modulate TLR4-mediated signaling have great therapeutic potential. Recently, we have reported a series of monophosphorylated lipid A mimics as potential ligands of TLR4, in which a diethanolamine moiety is employed to replace the reducing end (D-glucosamine). In this paper, we describe the synthesis of two further diethanolamine-containing lipid A mimics, 3 and 4, in an effort to mimic more closely the di-phosphate nature of natural lipid A. Both mimic 3, with an additional phosphate on the diethanolamine acyclic scaffold, and mimic 4, with a terminal carboxylic acid moiety as a phosphate bioisostere, serve to increase the potency of the immunostimulatory response induced, as measured by the induction of the cytokines TNF-alpha, IL-6, and IL-1 beta in the human monocytic cell line THP-1. In addition, mechanistic studies involving the known TLR4 antagonist lipid IVa confirm TLR4 as the target of the diethanolamine-containing lipid A mimics. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2013.02.024
  • 作为产物:
    参考文献:
    名称:
    Improving the immunostimulatory potency of diethanolamine-containing lipid A mimics
    摘要:
    Lipid A is the active principal of gram negative bacterial lipopolysaccharide (LPS) in the activation of Toll-like receptor 4 (TLR4). Given the important role TLR4 plays in innate immunity and the development of adaptive immune responses, ligands that can modulate TLR4-mediated signaling have great therapeutic potential. Recently, we have reported a series of monophosphorylated lipid A mimics as potential ligands of TLR4, in which a diethanolamine moiety is employed to replace the reducing end (D-glucosamine). In this paper, we describe the synthesis of two further diethanolamine-containing lipid A mimics, 3 and 4, in an effort to mimic more closely the di-phosphate nature of natural lipid A. Both mimic 3, with an additional phosphate on the diethanolamine acyclic scaffold, and mimic 4, with a terminal carboxylic acid moiety as a phosphate bioisostere, serve to increase the potency of the immunostimulatory response induced, as measured by the induction of the cytokines TNF-alpha, IL-6, and IL-1 beta in the human monocytic cell line THP-1. In addition, mechanistic studies involving the known TLR4 antagonist lipid IVa confirm TLR4 as the target of the diethanolamine-containing lipid A mimics. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2013.02.024
点击查看最新优质反应信息